Key statistics
On Thursday, Mink Therapeutics Inc (INKT:NAQ) closed at 0.767, 7.88% above its 52-week low of 0.711, set on Sep 18, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.73 |
---|---|
High | 0.7853 |
Low | 0.72 |
Bid | 0.7403 |
Offer | 0.7796 |
Previous close | 0.74 |
Average volume | 25.44k |
---|---|
Shares outstanding | 39.54m |
Free float | 10.02m |
P/E (TTM) | -- |
Market cap | 30.33m USD |
EPS (TTM) | -0.4891 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- MiNK Therapeutics to Participate in H.C. Wainwright Global Investment Conference
- MiNK Reports Second Quarter 2024 Results and Business Update
- MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
- MiNK Therapeutics Regains Compliance with Nasdaq Capital Market Requirement
- MiNK Therapeutics Announces Virtual Annual Shareholders Meeting
- MiNK Presents AgenT-797 Clinical Activity in Immune-Compromised Transplant Patient with Severe ARDS at ATS Annual Meeting
- MiNK Reports First Quarter 2024 Results
- MiNK Therapeutics Announces $5.8 Million Private Placement and Appointment of Board Observer
- MiNK to Provide Corporate Update and First Quarter 2024 Financial Report
- MiNK Therapeutics Announces Promising Preclinical Activity of MiNK-215 Against Colorectal Cancer Liver Metastases at AACR
More ▼